FDA.reportPublic FDA data

insulin aspart 100 UNT/ML Injectable Solution

RxCUI
311040
RxNorm name
insulin aspart 100 UNT/ML Injectable Solution
Display name
insulin aspart 100 UNT/ML Injectable Solution
Full name
insulin aspart 100 UNT/ML Injectable Solution
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:38:54

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
020986Novologinsulin aspart351(a)Rx2026-07-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Insulin AspartINSULIN ASPARTA-S Medication Solutionsbfd2b192-35e5-4773-ab73-802565b2ad782024-03-14Warnings, Adverse reactionsExact identifier
rxcui: 311040
NOVOLOGINSULIN ASPARTA-S Medication Solutionse172b4f8-9b25-4019-8e09-afc10b2f30c92023-12-09Warnings, Adverse reactionsExact identifier
rxcui: 311040
Insulin AspartINSULIN ASPARTNovo Nordisk Pharma, Inc.bee5b358-c863-420b-be73-ced2e920c4992023-02-28Warnings, Adverse reactionsExact identifier
rxcui: 311040
Insulin Diluting Medium for NovoLogWATER INJECTIONNovo Nordisk3a1e73a2-3009-40d0-876c-b4cb2be56fc52023-02-28Warnings, Adverse reactionsExact identifier
rxcui: 311040

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 5 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
3a1e73a2-3009-40d0-876c-b4cb2be56fc5insulin aspart 100 UNT/ML Injectable Solution [PSN] · insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart 100 UNT/ML Injectable Solution [SY]334These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 200020230228
e172b4f8-9b25-4019-8e09-afc10b2f30c9insulin aspart 100 UNT/ML Injectable Solution [PSN] · insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart 100 UNT/ML Injectable Solution [SY]328These highlights do not include all the information needed to use NOVOLOG safely and effectively. See full prescribing information for NOVOLOG. NOVOLOG ® (insulin aspart) injection, for subcutaneous or intravenous use Initial U.S. Approval: 200020231209
bfd2b192-35e5-4773-ab73-802565b2ad78insulin aspart 100 UNT/ML Injectable Solution [PSN] · insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart 100 UNT/ML Injectable Solution [SY]38These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).20240314
bee5b358-c863-420b-be73-ced2e920c499insulin aspart 100 UNT/ML Injectable Solution [PSN] · insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart 100 UNT/ML Injectable Solution [SY]35These highlights do not include all the information needed to use INSULIN ASPART safely and effectively. See full prescribing information for INSULIN ASPART. INSULIN ASPART injection, for subcutaneous or intravenous use Initial U.S. Approval: 2000 This product is NovoLog (insulin aspart).20230228
66472b3d-32c1-4803-aff4-b621aa5430b3insulin aspart 100 UNT/ML Injectable Solution [PSN] · insulin aspart, human 100 UNT/ML Injectable Solution [SCD] · insulin analog, aspart 100 UNT/ML Injectable Solution [SY]32These highlights do not include all the information needed to use NovoLog safely and effectively. See full prescribing information for NovoLog. NovoLog (insulin aspart [rDNA origin] injection) solution for subcutaneous use Initial U.S. Approval: 2000 ®20140425